IL66338A - Anti-cancer drugs comprising platinum complexed antitumor immunoglobulins - Google Patents
Anti-cancer drugs comprising platinum complexed antitumor immunoglobulinsInfo
- Publication number
- IL66338A IL66338A IL66338A IL6633882A IL66338A IL 66338 A IL66338 A IL 66338A IL 66338 A IL66338 A IL 66338A IL 6633882 A IL6633882 A IL 6633882A IL 66338 A IL66338 A IL 66338A
- Authority
- IL
- Israel
- Prior art keywords
- immunoglobulins
- platinum
- antitumor
- immunoglobulin
- tumor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL66338A IL66338A (en) | 1982-07-15 | 1982-07-15 | Anti-cancer drugs comprising platinum complexed antitumor immunoglobulins |
| CA000432233A CA1224718A (en) | 1982-07-15 | 1983-07-12 | Anti-cancer drugs comprising platinum complexes |
| AU16858/83A AU555324B2 (en) | 1982-07-15 | 1983-07-14 | Platinum-anti-tumor immunoglobulin complexes |
| EP83106965A EP0099133B1 (de) | 1982-07-15 | 1983-07-15 | Platinkomplexe enthaltende Antikrebsarzneimittel |
| JP58128057A JPS59130222A (ja) | 1982-07-15 | 1983-07-15 | 抗−腫瘍剤及びその調整方法 |
| DE8383106965T DE3378524D1 (en) | 1982-07-15 | 1983-07-15 | Anti-cancer drugs comprising platinum complexes |
| AT83106965T ATE38775T1 (de) | 1982-07-15 | 1983-07-15 | Platinkomplexe enthaltende antikrebsarzneimittel. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL66338A IL66338A (en) | 1982-07-15 | 1982-07-15 | Anti-cancer drugs comprising platinum complexed antitumor immunoglobulins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL66338A0 IL66338A0 (en) | 1982-11-30 |
| IL66338A true IL66338A (en) | 1986-03-31 |
Family
ID=11053640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL66338A IL66338A (en) | 1982-07-15 | 1982-07-15 | Anti-cancer drugs comprising platinum complexed antitumor immunoglobulins |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0099133B1 (de) |
| JP (1) | JPS59130222A (de) |
| AT (1) | ATE38775T1 (de) |
| AU (1) | AU555324B2 (de) |
| CA (1) | CA1224718A (de) |
| DE (1) | DE3378524D1 (de) |
| IL (1) | IL66338A (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0167310B1 (de) * | 1984-06-27 | 1991-05-29 | Johnson Matthey Public Limited Company | Platinkoordinationsverbindungen |
| US4952676A (en) * | 1984-06-27 | 1990-08-28 | Johnson Matthey Plc | Monoclonal antibody-platinum co-ordination compound complex |
| US4956454A (en) * | 1984-06-27 | 1990-09-11 | Johnson Matthey Plc | Monoclonal antibody - platinum co-ordination compound complex |
| EP0169645A1 (de) * | 1984-06-27 | 1986-01-29 | Johnson Matthey Public Limited Company | Platin-Koordinationsverbindungen |
| US5100877A (en) * | 1986-05-21 | 1992-03-31 | Kuraray Co., Ltd. | Platinum containing pullulan derivatives and pharmaceutical compositions comprising the same |
| WO1987007142A1 (fr) * | 1986-05-21 | 1987-12-03 | Kuraray Co., Ltd. | Nouveaux complexes, procede pour leur preparation, et leur emploi medicinal |
| US4793986A (en) * | 1987-02-25 | 1988-12-27 | Johnson Matthey, Inc. | Macromolecular platinum antitumor compounds |
| JP2520262B2 (ja) * | 1987-08-21 | 1996-07-31 | 春幸 川原 | パツチテスト材料 |
| CN104934660B (zh) * | 2015-07-14 | 2017-03-01 | 北京航空航天大学 | 一种便捷卷式超薄氧‑金属电池 |
| CN117383616B (zh) * | 2023-10-13 | 2024-11-01 | 广东医科大学 | 一种中空载药纳米酶、制备方法及抗肿瘤药物 |
-
1982
- 1982-07-15 IL IL66338A patent/IL66338A/xx unknown
-
1983
- 1983-07-12 CA CA000432233A patent/CA1224718A/en not_active Expired
- 1983-07-14 AU AU16858/83A patent/AU555324B2/en not_active Ceased
- 1983-07-15 AT AT83106965T patent/ATE38775T1/de active
- 1983-07-15 EP EP83106965A patent/EP0099133B1/de not_active Expired
- 1983-07-15 DE DE8383106965T patent/DE3378524D1/de not_active Expired
- 1983-07-15 JP JP58128057A patent/JPS59130222A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE3378524D1 (en) | 1988-12-29 |
| ATE38775T1 (de) | 1988-12-15 |
| IL66338A0 (en) | 1982-11-30 |
| CA1224718A (en) | 1987-07-28 |
| JPS59130222A (ja) | 1984-07-26 |
| EP0099133A3 (en) | 1984-09-05 |
| AU555324B2 (en) | 1986-09-18 |
| AU1685883A (en) | 1984-01-19 |
| EP0099133A2 (de) | 1984-01-25 |
| EP0099133B1 (de) | 1988-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL47372A0 (en) | Fab'dimers bound to anti-cancer drugs | |
| EP0287317A3 (de) | Platinkomplexe mit einem strahlensensibilisierenden Liganden | |
| IL66338A (en) | Anti-cancer drugs comprising platinum complexed antitumor immunoglobulins | |
| KE3590A (en) | Platinum-diamine complexes,a method for the preparation thereof,a method for the preparation of a medicine using such a platinum-diamine complex for the treatment of cancer,as well as a medicine thus formed | |
| AU559983B2 (en) | Platinum complexes, treatment of cancer | |
| BE895990A (fr) | Preparation de complexes de nickel de valence zero | |
| ES8604070A1 (es) | Un metodo para preparar un complejo platinoso | |
| IL75361A0 (en) | Tumor cell growth-inhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold,silver or copper complexes | |
| HUT40452A (en) | Process for preparing tumor inhibiting (1-benzyl-ethylene-diamine)-platinum(ii) complexes | |
| US4536386B1 (en) | Method of controlling emesis caused by cisplatin in cancer chemotherapy | |
| IE850226L (en) | Antitumor compositions employing £x, w-bis (disubstituted¹phosphino) - hydrocarbon|digold, disilverand dicopper¹derivatives | |
| NL189965C (nl) | Triarylboraanisocyanometaalcomplexen. | |
| DE3577709D1 (de) | Platin-intercalativ-komplexe zur behandlung von krebs. | |
| DE3578180D1 (de) | Aminoanthracendione-platin-komplexe fuer anti-krebs-verbindungen. | |
| GB2131020B (en) | Improvements relating to compounds useful in radiotherapy or chemotherapy | |
| ZA854905B (en) | Cis-platinum(ii)complexes with diamino-sugar derivatives as ligands,processes for their preparation and medicaments containing these complexes | |
| HUT39323A (en) | Herbicides and fungicides containing as reagent derivatives of tetrahydro-kynolin-1-il-carbonil-imidazol and process for production of the reagent | |
| GB1166110A (en) | Substituted Thiocyano Pyrroles, Fungicidal preparations containing these Compounds as Active Ingredients and methods of using the same | |
| DE3572979D1 (en) | Treatment of hydrocarbon solutions of dialkylmagnesium compounds to reduce the content of soluble chloridecontaining complexes | |
| DE3379465D1 (en) | Substituted cyclopentadienyl cobalt complexes and synthesis of pyridine homologues by means of the complexes | |
| ZA855862B (en) | Amino-anthracenediones-platinum complexes useful as anti-cancer compounds | |
| JPS57159798A (en) | Cis-platinum(ii) complex compound having saccharides derivative as ligand | |
| AU1895583A (en) | Ce diketonate complexes | |
| DK349384A (da) | Ph-regulerende fodertilskud | |
| GB2165046B (en) | Ligand molecule |